MiR-27a-3p functions as an oncogene in gastric cancer by targeting BTG2

Lin Zhou1, Xin Liang2, Lingling Zhang2

  • 1Department of Laboratory Medicine, Changzhen Hospital, Second Military Medical University, Shanghai 200003, China.

Oncotarget
|July 14, 2016
PubMed

Insights

MicroRNA-27a-3p (miR-27a-3p) promotes gastric cancer by targeting B-cell translocation gene 2 (BTG2). This miR-27a-3p/BTG2 axis is a potential diagnostic biomarker and therapeutic target for gastric cancer.

Area of Science:

  • Molecular biology
  • Oncology
  • Biochemistry

Background:

  • MicroRNA-27a (miR-27a) is dysregulated in human cancers, including gastric cancer.
  • B-cell translocation gene 2 (BTG2) plays a role in gastric carcinogenesis.
  • The relationship between miR-27a and BTG2 in gastric cancer remains unexplored.

Purpose of the Study:

  • To investigate the role of miR-27a isoforms in gastric cancer.
  • To identify the target gene of miR-27a in gastric cancer.
  • To elucidate the functional mechanism of the miR-27a/BTG2 axis in gastric carcinogenesis.

Main Methods:

  • Quantitative real-time PCR to measure miR-27a and BTG2 expression.
  • In vitro cell proliferation assays and in vivo tumor growth studies.
  • Western blotting and luciferase reporter assays to confirm target interaction and pathway analysis.

Main Results:

  • Both miR-27a-5p and miR-27a-3p were overexpressed in gastric cancer tissues and cell lines, with miR-27a-3p showing higher expression.
  • Overexpression of miR-27a-3p promoted gastric cancer cell proliferation and tumor growth.
  • BTG2 was identified as a direct target of miR-27a-3p; miR-27a-3p inhibition upregulated BTG2, which induced cell cycle arrest, apoptosis, and inhibited C-myc activation via the Ras/MEK/ERK pathway.

Conclusions:

  • The miR-27a-3p/BTG2 axis plays a critical role in gastric carcinogenesis and progression.
  • miR-27a-3p promotes gastric cancer by downregulating BTG2.
  • The miR-27a-3p/BTG2 axis represents a potential diagnostic biomarker and therapeutic target for gastric cancer.

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.3K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.9K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
11.8K